Martin Huelsmeyer

发表

Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK/PD Properties for the Treatment of Anemia in Different Patient Populations

L. Audoly, A. Skerra, R. Belaiba, 2011 .

Chapter 13: Formulation Development for Biologics Utilizing Lab Automation and In Vivo Performance Models

Michael Siedler, Sabine Eichling, Martin Huelsmeyer, 2020 .